Principles of T2*‐weighted dynamic susceptibility contrast MRI technique in brain tumor imaging
暂无分享,去创建一个
James M. Provenzale | Max Wintermark | Meng Law | Arnd Dörfler | Alex Rovira | Jerrold L. Boxerman | Mark S. Shiroishi | Gloria Castellazzi | Nicoletta Anzalone | M. Essig | M. Wintermark | J. Boxerman | À. Rovira | J. Provenzale | A. Dörfler | M. Shiroishi | G. Castellazzi | M. Law | T. Nguyen | D. Enterline | N. Anzalone | Marco Essig | Francesco D’Amore | T. B. Nguyen | David S. Enterline | Francesco D’Amore
[1] K. Schmainda. Perfusion Imaging for Brain Tumor Characterization and Assessment of Treatment Response , 2016 .
[2] F. Calamante. Arterial input function in perfusion MRI: a comprehensive review. , 2013, Progress in nuclear magnetic resonance spectroscopy.
[3] Fernando Calamante,et al. The 39 steps: evading error and deciphering the secrets for accurate dynamic susceptibility contrast MRI , 2013, NMR in biomedicine.
[4] J. Boxerman,et al. The Effect of Pulse Sequence Parameters and Contrast Agent Dose on Percentage Signal Recovery in DSC-MRI: Implications for Clinical Applications , 2013, American Journal of Neuroradiology.
[5] W. Rooney,et al. Pseudoprogression of glioblastoma after chemo- and radiation therapy: diagnosis by using dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging with ferumoxytol versus gadoteridol and correlation with survival. , 2013, Radiology.
[6] Max Wintermark,et al. Perfusion MRI: the five most frequently asked clinical questions. , 2013, AJR. American journal of roentgenology.
[7] M. Essig,et al. Perfusion MRI: the five most frequently asked technical questions. , 2013, AJR. American journal of roentgenology.
[8] Peter Reimer,et al. Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines , 2013, European Radiology.
[9] V. Runge,et al. MRI contrast agents: Basic chemistry and safety , 2012, Journal of magnetic resonance imaging : JMRI.
[10] Namkug Kim,et al. Percent change of perfusion skewness and kurtosis: a potential imaging biomarker for early treatment response in patients with newly diagnosed glioblastomas. , 2012, Radiology.
[11] G. Zaharchuk,et al. Combined spin‐ and gradient‐echo perfusion‐weighted imaging , 2012, Magnetic resonance in medicine.
[12] J. Boxerman,et al. The Role of Preload and Leakage Correction in Gadolinium-Based Cerebral Blood Volume Estimation Determined by Comparison with MION as a Criterion Standard , 2012, American Journal of Neuroradiology.
[13] Andrew G Webb,et al. Evaluation of signal formation in local arterial input function measurements of dynamic susceptibility contrast MRI , 2012, Magnetic resonance in medicine.
[14] J. Wardlaw,et al. Systematic Review of Perfusion Imaging With Computed Tomography and Magnetic Resonance in Acute Ischemic Stroke: Heterogeneity of Acquisition and Postprocessing Parameters A Translational Medicine Research Collaboration Multicentre Acute Stroke Imaging Study , 2012, Stroke.
[15] J. Burdette,et al. Does MR Perfusion Imaging Impact Management Decisions for Patients with Brain Tumors? A Prospective Study , 2011, American Journal of Neuroradiology.
[16] Xin Li,et al. Improved perfusion MR imaging assessment of intracerebral tumor blood volume and antiangiogenic therapy efficacy in a rat model with ferumoxytol. , 2011, Radiology.
[17] T. Hirai,et al. Quantitative Blood Flow Measurements in Gliomas Using Arterial Spin-Labeling at 3T: Intermodality Agreement and Inter- and Intraobserver Reproducibility Study , 2011, American Journal of Neuroradiology.
[18] Glyn Johnson,et al. An improved model for describing the contrast bolus in perfusion MRI. , 2011, Medical physics.
[19] Dong Liang,et al. Pharmacokinetics and magnetic resonance imaging of biodegradable macromolecular blood-pool contrast agent PG-Gd in non-human primates: a pilot study. , 2011, Contrast media & molecular imaging.
[20] Kenneth K. Kwong,et al. Early time points perfusion imaging: Theoretical analysis of correction factors for relative cerebral blood flow estimation given local arterial input function , 2011, NeuroImage.
[21] Alan Connelly,et al. Validating a Local Arterial Input Function Method for Improved Perfusion Quantification in Stroke , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[22] Wen-Chau Wu,et al. Pseudocontinuous arterial spin labeling perfusion magnetic resonance imaging—A normative study of reproducibility in the human brain , 2011, NeuroImage.
[23] S Ekholm,et al. Percentage Signal Recovery Derived from MR Dynamic Susceptibility Contrast Imaging Is Useful to Differentiate Common Enhancing Malignant Lesions of the Brain , 2011, American Journal of Neuroradiology.
[24] Yufen Chen,et al. Test–retest reliability of arterial spin labeling with common labeling strategies , 2011, Journal of magnetic resonance imaging : JMRI.
[25] A Gregory Sorensen,et al. Diffusion and diffusion tensor imaging in brain cancer. , 2011, Seminars in radiation oncology.
[26] D. Kong,et al. Diagnostic Dilemma of Pseudoprogression in the Treatment of Newly Diagnosed Glioblastomas: The Role of Assessing Relative Cerebral Blood Flow Volume and Oxygen-6-Methylguanine-DNA Methyltransferase Promoter Methylation Status , 2011, American Journal of Neuroradiology.
[27] William D Rooney,et al. Potential for differentiation of pseudoprogression from true tumor progression with dynamic susceptibility-weighted contrast-enhanced magnetic resonance imaging using ferumoxytol vs. gadoteridol: a pilot study. , 2011, International journal of radiation oncology, biology, physics.
[28] C. Zee,et al. Perfusion and Permeability MR Imaging of Gliomas , 2011, Technology in cancer research & treatment.
[29] Marilyn Albert,et al. Reliability and reproducibility of perfusion MRI in cognitively normal subjects. , 2010, Magnetic resonance imaging.
[30] E. Melhem,et al. Dynamic susceptibility contrast perfusion weighted imaging in grading of nonenhancing astrocytomas , 2010, Journal of magnetic resonance imaging : JMRI.
[31] K. Schmainda,et al. Standardization of relative cerebral blood volume (rCBV) image maps for ease of both inter‐ and intrapatient comparisons , 2010, Magnetic resonance in medicine.
[32] A. Jackson,et al. Imaging of brain tumors: perfusion/permeability. , 2010, Neuroimaging clinics of North America.
[33] Andrew G Webb,et al. Phase‐based arterial input function measurements for dynamic susceptibility contrast MRI , 2010, Magnetic resonance in medicine.
[34] David C. Alsop,et al. Volumetric cerebral perfusion imaging in healthy adults: Regional distribution, laterality, and repeatability of pulsed continuous arterial spin labeling (PCASL) , 2010, Psychiatry Research: Neuroimaging.
[35] Matus Straka,et al. Combined arterial spin label and dynamic susceptibility contrast measurement of cerebral blood flow , 2010, Magnetic resonance in medicine.
[36] L. Astrakas,et al. Shifting from region of interest (ROI) to voxel-based analysis in human brain mapping , 2010, Pediatric Radiology.
[37] Timothy D Johnson,et al. Parametric response map as an imaging biomarker to distinguish progression from pseudoprogression in high-grade glioma. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[38] F. Calamante. Perfusion MRI Using Dynamic-Susceptibility Contrast MRI: Quantification Issues in Patient Studies , 2010, Topics in magnetic resonance imaging : TMRI.
[39] Gaohong Wu,et al. Reliability and precision of pseudo‐continuous arterial spin labeling perfusion MRI on 3.0 T and comparison with 15O‐water PET in elderly subjects at risk for Alzheimer's disease , 2010, NMR in biomedicine.
[40] Atle Bjørnerud,et al. A Fully Automated Method for Quantitative Cerebral Hemodynamic Analysis Using DSC–MRI , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[41] J. Debbins,et al. Optimized Preload Leakage-Correction Methods to Improve the Diagnostic Accuracy of Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging in Posttreatment Gliomas , 2010, American Journal of Neuroradiology.
[42] Kim Mouridsen,et al. The QUASAR reproducibility study, Part II: Results from a multi-center Arterial Spin Labeling test–retest study , 2010, NeuroImage.
[43] M. Endo,et al. Perfusion weighted magnetic resonance imaging to distinguish the recurrence of metastatic brain tumors from radiation necrosis after stereotactic radiosurgery , 2010, Journal of Neuro-Oncology.
[44] M. Law,et al. Magnetic resonance perfusion and permeability imaging in brain tumors. , 2009, Neuroimaging clinics of North America.
[45] M. Berger,et al. Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. , 2009, Radiology.
[46] T E Yankeelov,et al. A theoretical framework to model DSC-MRI data acquired in the presence of contrast agent extravasation , 2009, Physics in medicine and biology.
[47] Dorothee P. Auer,et al. Quantitative imaging biomarkers in neuro-oncology , 2009, Nature Reviews Clinical Oncology.
[48] H. Kauczor,et al. Intraindividual comparison between gadopentetate dimeglumine and gadobutrol for magnetic resonance perfusion in normal brain and intracranial tumors at 3 tesla , 2009, Acta radiologica.
[49] Joseph A Maldjian,et al. Arterial spin-labeled MR perfusion imaging: clinical applications. , 2009, Magnetic resonance imaging clinics of North America.
[50] Timothy D Johnson,et al. The parametric response map is an imaging biomarker for early cancer treatment outcome , 2009, Nature Medicine.
[51] M. van Buchem,et al. Optimal Location for Arterial Input Function Measurements near the Middle Cerebral Artery in First-Pass Perfusion MRI , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[52] D. Knol,et al. Radiological progression of cerebral metastases after radiosurgery: assessment of perfusion MRI for differentiating between necrosis and recurrence , 2009, Journal of Neurology.
[53] Alan Connelly,et al. Perfusion precision in bolus‐tracking MRI: Estimation using the wild‐bootstrap method , 2009, Magnetic resonance in medicine.
[54] M R Segal,et al. Distinguishing Recurrent Intra-Axial Metastatic Tumor from Radiation Necrosis Following Gamma Knife Radiosurgery Using Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging , 2008, American Journal of Neuroradiology.
[55] Atam P. Dhawan,et al. Principles and Advanced Methods in Medical Imaging and Image Analysis , 2008, American Journal of Neuroradiology.
[56] Wanyong Shin,et al. Quantification of cerebral perfusion using the "bookend technique": an evaluation in CNS tumors. , 2008, Magnetic resonance imaging.
[57] A Gregory Sorensen,et al. Perfusion MR imaging: moving forward. , 2008, Radiology.
[58] K. Schmainda,et al. Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors. , 2008, Radiology.
[59] A. Jackson,et al. Magnetic resonance perfusion imaging in neuro-oncology , 2008, Cancer imaging : the official publication of the International Cancer Imaging Society.
[60] A. Bjørnerud,et al. Histogram Analysis of MR Imaging–Derived Cerebral Blood Volume Maps: Combined Glioma Grading and Identification of Low-Grade Oligodendroglial Subtypes , 2008, American Journal of Neuroradiology.
[61] A. Waldman,et al. Inclusion or Exclusion of Intratumoral Vessels in Relative Cerebral Blood Volume Characterization in Low-Grade Gliomas: Does It Make a Difference? , 2008, American Journal of Neuroradiology.
[62] Geoffrey A. Donnan,et al. Acute Stroke Imaging Research Roadmap , 2008, Stroke.
[63] A. Waldman,et al. Low-grade gliomas: do changes in rCBV measurements at longitudinal perfusion-weighted MR imaging predict malignant transformation? , 2008, Radiology.
[64] A. Sbarbati,et al. Tumor microvasculature observed using different contrast agents: a comparison between Gd-DTPA-Albumin and B-22956/1 in an experimental model of mammary carcinoma , 2008, Magnetic Resonance Materials in Physics, Biology and Medicine.
[65] E. Russell Ritenour,et al. Principles and Advanced Methods in Medical Imaging and Image Analysis , 2008, American Journal of Neuroradiology.
[66] Wanyong Shin,et al. Quantitative cerebral perfusion using dynamic susceptibility contrast MRI: Evaluation of reproducibility and age‐ and gender‐dependence with fully automatic image postprocessing algorithm , 2007, Magnetic resonance in medicine.
[67] G. Zaharchuk,et al. Theoretical Basis of Hemodynamic MR Imaging Techniques to Measure Cerebral Blood Volume, Cerebral Blood Flow, and Permeability , 2007, American Journal of Neuroradiology.
[68] Timothy P L Roberts,et al. Neuro MR: Principles , 2007, Journal of magnetic resonance imaging : JMRI.
[69] Roland Bammer,et al. Perfusion mapping with multiecho multishot parallel imaging EPI , 2007, Magnetic resonance in medicine.
[70] Michael Hermes,et al. Reproducibility of continuous arterial spin labeling perfusion MRI after 7 weeks , 2007, Magnetic Resonance Materials in Physics, Biology and Medicine.
[71] G Johnson,et al. Histogram analysis versus region of interest analysis of dynamic susceptibility contrast perfusion MR imaging data in the grading of cerebral gliomas. , 2007, AJNR. American journal of neuroradiology.
[72] Hamid Krim,et al. An Independent Component Analysis Approach for Minimizing Effects of Recirculation in Dynamic Susceptibility Contrast Magnetic Resonance Imaging , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[73] Iwao Kanno,et al. Cerebral Vascular Mean Transit Time in Healthy Humans: A Comparative Study with PET and Dynamic Susceptibility Contrast-Enhanced MRI , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[74] Susan M. Chang,et al. Feasibility of dynamic susceptibility contrast perfusion MR imaging at 3T using a standard quadrature head coil and eight‐channel phased‐array coil with and without SENSE reconstruction , 2006, Journal of magnetic resonance imaging : JMRI.
[75] Finbarr O'Sullivan,et al. Experimental Estimates of the Constants Relating Signal Change to Contrast Concentration for Cerebral Blood Volume by T2* MRI , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[76] Renate Grüner,et al. Iterative blind deconvolution in magnetic resonance brain perfusion imaging , 2006, Magnetic resonance in medicine.
[77] R M Weisskoff,et al. Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. , 2006, AJNR. American journal of neuroradiology.
[78] Søren Christensen,et al. Automatic selection of arterial input function using cluster analysis , 2006, Magnetic resonance in medicine.
[79] Renate Grüner,et al. Magnetic resonance brain perfusion imaging with voxel‐specific arterial input functions , 2006, Journal of magnetic resonance imaging : JMRI.
[80] Glyn Johnson,et al. Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging--prediction of patient clinical response. , 2006, Radiology.
[81] E. Akbudak,et al. Arterial input functions for dynamic susceptibility contrast MRI: Requirements and signal options , 2005, Journal of magnetic resonance imaging : JMRI.
[82] J. Mintorovitch,et al. Comparison of Magnetic Properties of MRI Contrast Media Solutions at Different Magnetic Field Strengths , 2005, Investigative radiology.
[83] Emmanuel L Barbier,et al. Comparative Overview of Brain Perfusion Imaging Techniques , 2005, Journal of neuroradiology. Journal de neuroradiologie.
[84] B. D. Ward,et al. Improving the reliability of obtaining tumor hemodynamic parameters in the presence of contrast agent extravasation , 2005, Magnetic resonance in medicine.
[85] Wanyong Shin,et al. Method for improving the accuracy of quantitative cerebral perfusion imaging , 2005, Journal of magnetic resonance imaging : JMRI.
[86] Bradford A Moffat,et al. Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[87] Hans H Schild,et al. Three-dimensional dynamic susceptibility-weighted perfusion MR imaging at 3.0 T: feasibility and contrast agent dose. , 2005, Radiology.
[88] N. Schuff,et al. Human brain: reliability and reproducibility of pulsed arterial spin-labeling perfusion MR imaging. , 2005, Radiology.
[89] F. Calamante. Quantification of Dynamic Susceptibility Contrast T2* MRI in Oncology , 2005 .
[90] David R Vera,et al. Gadolinium-DTPA-dextran: a macromolecular MR blood pool contrast agent. , 2004, Academic radiology.
[91] Tong San Koh,et al. Assessment of perfusion by dynamic contrast-enhanced imaging using a deconvolution approach based on regression and singular value decomposition , 2004, IEEE Transactions on Medical Imaging.
[92] Gregory S Karczmar,et al. Estimating the arterial input function using two reference tissues in dynamic contrast‐enhanced MRI studies: Fundamental concepts and simulations , 2004, Magnetic resonance in medicine.
[93] B. D. Ward,et al. Characterization of a first-pass gradient-echo spin-echo method to predict brain tumor grade and angiogenesis. , 2004, AJNR. American journal of neuroradiology.
[94] L. K. Hansen,et al. Defining a local arterial input function for perfusion MRI using independent component analysis , 2004, Magnetic resonance in medicine.
[95] Joop A. Peters,et al. A gadolinium(III) complex of a carboxylic-phosphorus acid derivative of diethylenetriamine covalently bound to inulin, a potential macromolecular MRI contrast agent. , 2004, Bioconjugate chemistry.
[96] Glyn Johnson,et al. Measuring blood volume and vascular transfer constant from dynamic, T 2* ‐weighted contrast‐enhanced MRI , 2004, Magnetic resonance in medicine.
[97] P. Tofts,et al. Normal cerebral perfusion measurements using arterial spin labeling: Reproducibility, stability, and age and gender effects , 2004, Magnetic resonance in medicine.
[98] A. Jackson,et al. Analysis of dynamic contrast enhanced MRI. , 2004, The British journal of radiology.
[99] Glyn Johnson,et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. , 2003, AJNR. American journal of neuroradiology.
[100] S. Atlas,et al. Magnetic resonance image–guided proteomics of human glioblastoma multiforme , 2003, Journal of magnetic resonance imaging : JMRI.
[101] Scott D Rand,et al. The effect of brain tumor angiogenesis on the in vivo relationship between the gradient‐echo relaxation rate change (ΔR2*) and contrast agent (MION) dose , 2003, Journal of magnetic resonance imaging : JMRI.
[102] Jeroen van der Grond,et al. Model of the human vasculature for studying the influence of contrast injection speed on cerebral perfusion MRI , 2003, Magnetic resonance in medicine.
[103] B. Rosen,et al. Tracer arrival timing‐insensitive technique for estimating flow in MR perfusion‐weighted imaging using singular value decomposition with a block‐circulant deconvolution matrix , 2003, Magnetic resonance in medicine.
[104] Pratik Mukherjee,et al. Measurement of cerebral blood flow in chronic carotid occlusive disease: comparison of dynamic susceptibility contrast perfusion MR imaging with positron emission tomography. , 2003, AJNR. American journal of neuroradiology.
[105] V. Haughton,et al. Automatic calculation of the arterial input function for cerebral perfusion imaging with MR imaging. , 2003, Radiology.
[106] M. Westphal,et al. Cost of migration: invasion of malignant gliomas and implications for treatment. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[107] A. Sorensen,et al. Do highly concentrated gadolinium chelates improve MR brain perfusion imaging? Intraindividually controlled randomized crossover concentration comparison study of 0.5 versus 1.0 mol/L gadobutrol. , 2003, Radiology.
[108] Massimo Filippi,et al. Diffusion-Weighted MRI , 2003 .
[109] C. Grandin. Assessment of brain perfusion with MRI: methodology and application to acute stroke , 2003, Neuroradiology.
[110] H. Aronen,et al. Dynamic susceptibility contrast MRI of gliomas. , 2002, Neuroimaging clinics of North America.
[111] Timothy J Carroll,et al. Absolute Quantification of Cerebral Blood Flow with Magnetic Resonance, Reproducibility of the Method, and Comparison with H215O Positron Emission Tomography , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[112] Glyn Johnson,et al. Relative cerebral blood volume measurements in intracranial mass lesions: interobserver and intraobserver reproducibility study. , 2002, Radiology.
[113] V. Haughton,et al. Confounding effect of large vessels on MR perfusion images analyzed with independent component analysis. , 2002, AJNR. American journal of neuroradiology.
[114] Narter Ari,et al. Test‐retest reproducibility of quantitative CBF measurements using FAIR perfusion MRI and acetazolamide challenge , 2002, Magnetic resonance in medicine.
[115] Leif Østergaard,et al. Evaluation of four postprocessing methods for determination of cerebral blood volume and mean transit time by dynamic susceptibility contrast imaging , 2002, Magnetic resonance in medicine.
[116] Glyn Johnson,et al. Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. , 2002, Radiology.
[117] D G Gadian,et al. Quantification of Perfusion Using Bolus Tracking Magnetic Resonance Imaging in Stroke: Assumptions, Limitations, and Potential Implications for Clinical Use , 2002, Stroke.
[118] D. Gadian,et al. Is quantification of bolus tracking MRI reliable without deconvolution? , 2002, Magnetic resonance in medicine.
[119] P. Permi. A spin-state-selective experiment for measuring heteronuclear one-bond and homonuclear two-bond couplings from an HSQC-type spectrum , 2002, Journal of biomolecular NMR.
[120] S. Trattnig. [3 Tesla magnetic resonance tomography--clinical applications]. , 2002, Wiener medizinische Wochenschrift. Supplement.
[121] M. Shinohara,et al. Accuracy of deconvolution analysis based on singular value decomposition for quantification of cerebral blood flow using dynamic susceptibility contrast-enhanced magnetic resonance imaging. , 2001, Physics in medicine and biology.
[122] W. Lin,et al. Quantitative measurements of cerebral blood flow in patients with unilateral carotid artery occlusion: A PET and MR study , 2001, Journal of magnetic resonance imaging : JMRI.
[123] V. Kiselev. On the theoretical basis of perfusion measurements by dynamic susceptibility contrast MRI , 2001, Magnetic resonance in medicine.
[124] I. Wilkinson,et al. Brain MR perfusion imaging in humans: Advantages of high-molarity gadolinium chelates , 2001 .
[125] I. Wilkinson,et al. Brain MR perfusion imaging in humans. , 2001, Acta radiologica.
[126] A. Jackson,et al. Reproducibility of T2* blood volume and vascular tortuosity maps in cerebral gliomas , 2001, Journal of magnetic resonance imaging : JMRI.
[127] Y Yonekura,et al. Blood volume of gliomas determined by double-echo dynamic perfusion-weighted MR imaging: a preliminary study. , 2001, AJNR. American journal of neuroradiology.
[128] M. Takahashi,et al. Perfusion-sensitive MR imaging of gliomas: comparison between gradient-echo and spin-echo echo-planar imaging techniques. , 2001, AJNR. American journal of neuroradiology.
[129] P F Renshaw,et al. Test–retest reliability of DSC MRI CBV mapping in healthy volunteers , 2001, Neuroreport.
[130] M. Lev,et al. Dynamic contrast-enhanced brain perfusion imaging: technique and clinical applications. , 2000, Seminars in ultrasound, CT, and MR.
[131] K Scheffler,et al. Analysis of input functions from different arterial branches with gamma variate functions and cluster analysis for quantitative blood volume measurements. , 2000, Magnetic resonance imaging.
[132] O Speck,et al. Perfusion MRI of the human brain with dynamic susceptibility contrast: Gradient‐echo versus spin‐echo techniques , 2000, Journal of magnetic resonance imaging : JMRI.
[133] C B Grandin,et al. Whole brain quantitative CBF, CBV, and MTT measurements using MRI bolus tracking: Implementation and application to data acquired from hyperacute stroke patients , 2000, Journal of magnetic resonance imaging : JMRI.
[134] M Wannenmacher,et al. Radiation-induced regional cerebral blood volume (rCBV) changes in normal brain and low-grade astrocytomas: quantification and time and dose-dependent occurrence. , 2000, International journal of radiation oncology, biology, physics.
[135] J. Petrella,et al. MR perfusion imaging of the brain: techniques and applications. , 2000, AJR. American journal of roentgenology.
[136] N. Chuang,et al. Neuroimaging: do we really need new contrast agents for MRI? , 2000, European journal of radiology.
[137] M A Viergever,et al. Simultaneous quantitative cerebral perfusion and Gd‐DTPA extravasation measurement with dual‐echo dynamic susceptibility contrast MRI , 2000, Magnetic resonance in medicine.
[138] A P Pathak,et al. Utility of simultaneously acquired gradient‐echo and spin‐echo cerebral blood volume and morphology maps in brain tumor patients , 2000, Magnetic resonance in medicine.
[139] A. Jackson,et al. Abnormalities of the contrast re‐circulation phase in cerebral tumors demonstrated using dynamic susceptibility contrast‐enhanced imaging: A possible marker of vascular tortuosity , 2000, Journal of magnetic resonance imaging : JMRI.
[140] Jayaram K. Udupa,et al. New variants of a method of MRI scale standardization , 2000, IEEE Transactions on Medical Imaging.
[141] L G Nyúl,et al. On standardizing the MR image intensity scale , 1999, Magnetic resonance in medicine.
[142] David L. Thomas,et al. Measuring Cerebral Blood Flow Using Magnetic Resonance Imaging Techniques , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[143] Jianfeng Gao,et al. Cerebral blood flow measurement by dynamic contrast MRI using singular value decomposition with an adaptive threshold , 1999, Magnetic resonance in medicine.
[144] S. Posse,et al. Analytical model of susceptibility‐induced MR signal dephasing: Effect of diffusion in a microvascular network , 1999, Magnetic resonance in medicine.
[145] Leif Østergaard,et al. CBF and CBV measurements by USPIO bolus tracking: Reproducibility and comparison with Gd‐based values , 1999, Journal of magnetic resonance imaging : JMRI.
[146] P. Johannsen,et al. Cerebral Blood Flow Measurements by Magnetic Resonance Imaging Bolus Tracking: Comparison with [15O]H2O Positron Emission Tomography in Humans , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[147] T. Benner,et al. Perfusion‐weighted MRI using gadobutrol as a contrast agent in a rat stroke model , 1997, Journal of magnetic resonance imaging : JMRI.
[148] Supun Samarasekera,et al. Multiple sclerosis lesion quantification using fuzzy-connectedness principles , 1997, IEEE Transactions on Medical Imaging.
[149] B. Rosen,et al. Signal‐to‐noise analysis of cerebral blood volume maps from dynamic NMR imaging studies , 1997, Journal of magnetic resonance imaging : JMRI.
[150] B. Rosen,et al. Contrast‐to‐noise ratio in functional MRI of relative cerebral blood volume with sprodiamide injection , 1997, Journal of magnetic resonance imaging : JMRI.
[151] B. Rosen,et al. Contrast agents in functional MR imaging , 1997, Journal of magnetic resonance imaging : JMRI.
[152] B. Rosen,et al. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: Experimental comparison and preliminary results , 1996, Magnetic resonance in medicine.
[153] B. Rosen,et al. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis , 1996, Magnetic resonance in medicine.
[154] R. Felix,et al. Comparison of gadolinium-DTPA and macromolecular gadolinium-DTPA-polylysine for contrast-enhanced pulmonary time-of-flight magnetic resonance angiography. , 1996, Investigative radiology.
[155] P. Renshaw,et al. Sequential dynamic susceptibility contrast MR experiments in human brain: Residual contrast agent effect, steady state, and hemodynamic perturbation , 1995, Magnetic resonance in medicine.
[156] B R Rosen,et al. Mr contrast due to intravascular magnetic susceptibility perturbations , 1995, Magnetic resonance in medicine.
[157] W. J. Lorenz,et al. Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging. , 1994, Radiology.
[158] E. Haacke,et al. Theory of NMR signal behavior in magnetically inhomogeneous tissues: The static dephasing regime , 1994, Magnetic resonance in medicine.
[159] B. Rosen,et al. Microscopic susceptibility variation and transverse relaxation: Theory and experiment , 1994, Magnetic resonance in medicine.
[160] E F Halpern,et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. , 1994, Radiology.
[161] T Kubota,et al. Tumor vascularity in the brain: evaluation with dynamic susceptibility-contrast MR imaging. , 1993, Radiology.
[162] L O Hall,et al. Review of MR image segmentation techniques using pattern recognition. , 1993, Medical physics.
[163] B. Rosen,et al. Pitfalls in MR measurement of tissue blood flow with intravascular tracers: Which mean transit time? , 1993, Magnetic resonance in medicine.
[164] V. Runge,et al. Assessment of cerebral perfusion by first-pass, dynamic, contrast-enhanced, steady-state free-precession MR imaging: an animal study. , 1993, AJR. American journal of roentgenology.
[165] R. Kikinis,et al. Routine quantitative analysis of brain and cerebrospinal fluid spaces with MR imaging , 1992, Journal of magnetic resonance imaging : JMRI.
[166] Mark S. Cohen,et al. Contrast agents and cerebral hemodynamics , 1991, Magnetic resonance in medicine.
[167] B. Rosen,et al. MR Contrast Due to Microscopically Heterogeneous Magnetic Susceptibility: Numerical Simulations and Applications to Cerebral Physiology , 1991, Magnetic resonance in medicine.
[168] R R Edelman,et al. Cerebral blood flow: assessment with dynamic contrast-enhanced T2*-weighted MR imaging at 1.5 T. , 1990, Radiology.
[169] J W Belliveau,et al. Functional cerebral imaging by susceptibility‐contrast NMR , 1990, Magnetic resonance in medicine.
[170] B. Rosen,et al. Perfusion imaging with NMR contrast agents , 1990, Magnetic resonance in medicine.
[171] D Chien,et al. Perfusion imaging by nuclear magnetic resonance. , 1989, Magnetic resonance quarterly.
[172] J C Gore,et al. Regional differences in rat brain displayed by fast MRI with superparamagnetic contrast agents. , 1988, Magnetic resonance imaging.
[173] B. Rosen,et al. Dynamic imaging with lanthanide chelates in normal brain: Contrast due to magnetic susceptibility effects , 1988, Magnetic resonance in medicine.
[174] A. Todd-Pokropek. Estimating Blood Flow by Deconvolution of the Injection of Radioisotope Tracers , 1988 .
[175] S. H. Koenig,et al. Transverse relaxation of solvent protons induced by magnetized spheres: Application to ferritin, erythrocytes, and magnetite , 1987, Magnetic resonance in medicine.
[176] N. Lassen,et al. Tracer kinetic methods in medical physiology , 1979 .
[177] T. Farrar. Chapter 4 – Relaxation Mechanisms , 1971 .
[178] K. Zierler,et al. On the theory of the indicator-dilution method for measurement of blood flow and volume. , 1954, Journal of applied physiology.